Clindamycin recalls
The FDA has published 11 recalls involving Clindamycin since 2016. The latest was reported on 14 May 2025. Most were for manufacturing (cgmp) deviations. Alvogen has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls11since 2016
Last 12 months0reported
Class I00% of total
Ongoing3latest 14 May 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 73%Class III 3 27%
Why clindamycin is recalled
Companies
By year
Ongoing clindamycin recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clindamycin HCl Capsule, 300 mg, QTY recalled by RemedyRePack | RemedyRePack | Manufacturing (CGMP) Deviations | FL, PA, VA |
| Drug | CLASS II | Clindamycin Hydrochloride Capsules, USP, 300mg recalled | Preferred Pharmaceuticals | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Clindamycin Hydrochloride Capsules, USP, 300mg recalledClindamycin Hydrochloride | Glenmark Pharmaceuticals Inc., U | Manufacturing (CGMP) Deviations | Nationwide |
All clindamycin recalls, newest first
11 totalShould you stop taking Clindamycin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.